Minoru Shirota: Difference between revisions
Content deleted Content added
Undid revision 1243443451 by 116.15.118.57 (talk) |
Undid revision 1243443381 by 116.15.118.57 (talk) |
||
| Line 13: | Line 13: | ||
| known_for = Invention of [[Yakult]] |
| known_for = Invention of [[Yakult]] |
||
}} |
}} |
||
{{nihongo|''' |
{{nihongo|'''Minoru Shirota'''|代田 稔|Shirota Minoru|extra=April 23, 1899 – March 10, 1982}} was a Japanese microbiologist. In the 1930 |
||
Shirota identified a strain of [[lactic acid bacteria]] that is part of normal [[gut flora]] that he originally called ''[[Lactobacillus casei]] Shirota,'' which appeared to help contain the growth of harmful bacteria in the gut. The strain was later reclassified as ''[[Lactobacillus paracasei]] Shirota''.<ref name=EFSA>{{cite journal |last1=EFSA Panel on Dietetic Products, Nutrition and Allergies |title=Scientific Opinion on the substantiation of a health claim related to Lactobacillus casei strain Shirota and maintenance of the upper respiratory tract defence against pathogens by maintaining immune defences pursuant to Article 13(5) of Regulation (EC) N |journal=EFSA Journal |date=October 2010 |volume=8 |issue=10 |pages=1860 |doi=10.2903/j.efsa.2010.1860|doi-access= }} {{open access}} Lay summary: {{cite news |last1=Wallop |first1=Harry |title=Probiotic drinks do not aid health, Europe says |url=https://www.telegraph.co.uk/news/health/news/8074182/Probiotic-drinks-do-not-aid-health-Europe-says.html |work=The Telegraph |date=20 October 2010}}</ref> |
Shirota identified a strain of [[lactic acid bacteria]] that is part of normal [[gut flora]] that he originally called ''[[Lactobacillus casei]] Shirota,'' which appeared to help contain the growth of harmful bacteria in the gut. The strain was later reclassified as ''[[Lactobacillus paracasei]] Shirota''.<ref name=EFSA>{{cite journal |last1=EFSA Panel on Dietetic Products, Nutrition and Allergies |title=Scientific Opinion on the substantiation of a health claim related to Lactobacillus casei strain Shirota and maintenance of the upper respiratory tract defence against pathogens by maintaining immune defences pursuant to Article 13(5) of Regulation (EC) N |journal=EFSA Journal |date=October 2010 |volume=8 |issue=10 |pages=1860 |doi=10.2903/j.efsa.2010.1860|doi-access= }} {{open access}} Lay summary: {{cite news |last1=Wallop |first1=Harry |title=Probiotic drinks do not aid health, Europe says |url=https://www.telegraph.co.uk/news/health/news/8074182/Probiotic-drinks-do-not-aid-health-Europe-says.html |work=The Telegraph |date=20 October 2010}}</ref> |
||
Latest revision as of 14:33, 1 September 2024
 | You can help expand this article with text translated from the corresponding article in Japanese. (August 2019) Click [show] for important translation instructions.
|
Minoru Shirota | |
|---|---|
 | |
| Born | 代田 稔 (Shirota Minoru) 23 April 1899 Tatsuoka, Nagano, Japan |
| Died | 10 March 1982 (aged 82) Tokyo, Japan |
| Occupation | Microbiologist |
| Known for | Invention of Yakult |
Minoru Shirota (代田 稔, Shirota Minoru, April 23, 1899 – March 10, 1982) was a Japanese microbiologist. In the 1930 Shirota identified a strain of lactic acid bacteria that is part of normal gut flora that he originally called Lactobacillus casei Shirota, which appeared to help contain the growth of harmful bacteria in the gut. The strain was later reclassified as Lactobacillus paracasei Shirota.[1]
He founded the company Yakult Honsha in 1935 to sell beverages containing the strain branded Yakult.[2]
He died in Tokyo, Japan in 1982.[citation needed]
References
[edit]- ^ EFSA Panel on Dietetic Products, Nutrition and Allergies (October 2010). "Scientific Opinion on the substantiation of a health claim related to Lactobacillus casei strain Shirota and maintenance of the upper respiratory tract defence against pathogens by maintaining immune defences pursuant to Article 13(5) of Regulation (EC) N". EFSA Journal. 8 (10): 1860. doi:10.2903/j.efsa.2010.1860.
Lay summary: Wallop, Harry (20 October 2010). "Probiotic drinks do not aid health, Europe says". The Telegraph.
- ^ Caramia, Giuseppe; Silvi, Stefania (2011). "Chapter 1: Probiotics: From the Ancient Wisdom to the Actual Therapeutical and Neutraceutical Perspective". In Malago, Joshua J.; Koninkx, Jos. F.J.G.; Marinsek-Logar, R. (eds.). Probiotic Bacteria and Enteric Infections Cytoprotection by Probiotic Bacteria. Dordrecht: Springer Science & Business Media. p. 6. ISBN 978-9-4007-0386-5.